The aim of this study was to analyze an association between milk consumption and serum lipid profiles in postmenopausal women in Korea. The dietary data by the Food Frequency Questionnaire were evaluated among 208 postmenopausal women who did not receive hormone therapy and their serum concentrations of triglyceride (TG), total, HDL-, and LDL-cholesterol, and alkaline phosphatase were analyzed. When the relationship between milk consumption and serum lipid profiles were analysed by linear regression, we found a negative relationship of milk consumption with ALP and a positive relationship with HDL-cholesterol. Animal calcium intake was significantly correlated with ALP and HDL-cholesterol. In addition, the serum level of HDL-cholesterol of the upper quartile (UQ) subjects who took animal calcium over 313 mg/day was significantly higher than the lower quartile (LQ) subjects who consumed milk below 101 mg/day when we compared the UQ and LQ subjects. The HDL-cholesterol level of the UQ subjects who consumed 235 ml of milk tended to be higher than the that of the LQ who consumed 53 ml. As for serum concentrations of TG, total cholesterol, and LDL-cholesterol, there was no significant difference between the UQ and LQ groups of milk consumption. Based on our study, we concluded that continual consumption of approximately one cup of milk per day was associated with low cardiovascular risks with favorable lipid profiles and ALP in postmenopausal women.
Alkaline Phosphatase ; Animals ; Calcium ; Cholesterol ; Female ; Humans ; Korea* ; Linear Models ; Menopause ; Milk* ; Surveys and Questionnaires ; Triglycerides

No abstract available.
Atrophy* ; Brain*

No abstract available.
Blood Platelets* ; Platelet Aggregation*

No abstract available.
Health Promotion*

No abstract available.
Health Promotion*

BACKGROUND: The pathogenic human parvovirus B19 is the etiologic agent of erythema infectiosum and causes other events including aplastic crisis,hydrops fetalis and fetal loss.Recently,it has been reported in many articles that human parvovirus B19 infection is associated with rheumatoid arthritis (RA).In contrast to these reports from the United Kingdom,Germany,Japan and China,different results were reported that there is no association between human parvovirus B19 and the pathogenesis of RA in Northern Ireland,Finland and France.This study aimed to investigate the association between human parvovirus B19 and RA in Korea. METHODS: Sera from 104 patients with RA,40 with osteoarthritis (OA)and 32 with systemic lupus erythematosus (SLE)were tested for IgG and IgM of human parvovirus B19 by ELISA (Biotrin),respectively. RESULTS: There were no statistical differences among RA,OA and SLE patients in both anti-human parvovirus B19 IgG and IgM (p>0.05).Human parvovirus B19 IgM was positive in only four RA patients and negative in all SLE and OA patients. CONCLUSION: Human parvovirus B19 infection showed no association with RA in Korea,which is different from reports from other countries,especially Japan and China which are our neighbors.We thought that this result was due to the ethnic or national differences of baseline titer of anti-human parvovirus B19.Therefore anti-human parvovirus B19 test for RA patients is not necessary in Korea.In conclusion,we suggest that the indication and interpretation of anti-human parvovirus B19 testing in RA patients should be applied differently for each nation.
Arthritis, Rheumatoid* ; China ; Enzyme-Linked Immunosorbent Assay ; Erythema Infectiosum ; Humans* ; Immunoglobulin G ; Immunoglobulin M ; Japan ; Korea* ; Lupus Erythematosus, Systemic ; Osteoarthritis ; Parvovirus ; Parvovirus B19, Human*

BACKGROUND: We compared the LightCycler MRSA advanced test (Roche Diagnostics, Germany) with enrichment culture methods to evaluate the relative diagnostic performance of the LightCycler MRSA advanced test for active surveillance in a high-prevalence setting. METHODS: A total of 342 nasal swab specimens were obtained from patients in the intensive care unit at admission and on the seventh day for follow-up. The results of LightCycler MRSA advanced test were compared to those of the enrichment culture. For discrepant results, mecA gene PCR was performed. RESULTS: For the detection of methicillin-resistant Staphylococcus aureus (MRSA), the LightCycler MRSA advanced test showed 98.5% sensitivity and 78.6% specificity and had positive and negative predictive values of 75.0% and 98.8%, respectively. A total of 46 samples had discrepant results between the LightCycler MRSA advanced test and enrichment culture. Of the 44 specimens that were positive in the LightCycler MRSA advanced test but negative by enrichment culture, mecA genes were detected in 37 specimens. In addition, of the original 44 cases, 21 patients had a history of MRSA colonization or infection within the last month; of those 21 specimens, 20 were positive for mecA gene as shown by PCR. Seven mecA-negative discrepant specimens comprised 3 methicillin-sensitive S. aureus-culture positive and only 2 patients had MRSA infections. CONCLUSIONS: Despite its low specificity and positive predictive value, the LightCycler MRSA advanced test could serve as a rapid test for patients colonized with MRSA.

BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is a major nasocomial pathogen. The active surveillance of MRSA is essential to limit its transmission. The BD GeneOhm MRSA real-time PCR assay (Becton Dickinson Diagnostics, San Diego, USA) has been recently developed and used for same-day MRSA detection directly from nasal swab specimens. The authors of the present study compared GeneOhm MRSA PCR with culture methods to evaluate its diagnostic performance for MRSA active surveillance. METHODS: The present study was conducted on patients admitted to the ICU for six months. A total of 371 nasal swab specimens were obtained from patients at admission day and at the seven-day follow-up. The swab was streaked onto culture media, and presumptive S. aureus colonies were confirmed as MRSA using the BD Phoenix automated microbiology system (Becton Dickinson Diagnostic Systems, Sparks, USA). In addition, GeneOhm MRSA PCR was performed. For discrepant results between Gene-Ohm MRSA PCR and culture, the enrichment broth culture method was performed. RESULTS: There were 34 samples with discrepant results between the GeneOhm MRSA PCR and culture. The overall agreement was 90.7%. For the detection of MRSA, the GeneOhm MRSA PCR was 96.8% sensitive and 86.3% specific, with positive and negative predictive values of 83.9% and 97.3%, respectively. CONCLUSION: Identification of MRSA-colonized patients was achieved in as little as two hours, and the high negative predictive value of GeneOhm MRSA PCR suggests that the assay is a rapid method for the identification of persons who are not colonized with MRSA. However, due to the low positive predictive value, GeneOhm MRSA PCR combined with enrichment culture in cases of positive GeneOhm MRSA PCR is potentially useful for active MRSA surveillance activities.
Colon ; Culture Media ; Follow-Up Studies ; Humans ; Methicillin-Resistant Staphylococcus aureus ; Polymerase Chain Reaction ; Real-Time Polymerase Chain Reaction

The most interesting change in anesthetic technic for pain relief during labor and delivery has been the widespread acceptance of continuous lumber epidural analgesia. Primary effect of epidural analgesia is to relieve pain and therapy to preserve the morale and to prevent exhaustion of the mother. For the past year in our hospital, continuous lumbar epidural analgesia was attempted on 38 pregnant women and its effect was assessed. In established labor, epidural analgesia was started for pain relief and was maintained with intermittent injections until delivery; in 45% the duration exceeded six hours. Labor was slightly retarded, probably due to inadvertent selection of patients with slow and painful progress. Vacuum extraction was used in 52.6%. Fetal condition was excellent(Apgar score of 7 or greater in 97.4%). Continuous epidural analgesia gives superior relief of pain but cells for experienced management and nursing care.
Analgesia, Epidural* ; Female ; Humans ; Morale ; Mothers ; Nursing Care ; Pregnant Women ; Vacuum

BACKGROUND: The pathogenic human parvovirus B19 replicates only in erythroid progenitor cells. The blood-group P antigen has been reported to be the cellular receptor of this virus. Human parvovirus B19 is known to be the etiologic agent of erythema infectiosum and causes a chronic anemia resulting from a persistent infection in immunocompromised patients. Recently, it has been re-ported to play a role in rheumatoid arthritis activity (RA). This study was aimed to determine whether human parvovirus B19 has a role to play in chronic anemia of RA which is the case in immunocompromised patients. We also investigated the association between the activity of the disease in RA and human parvovirus B19 infections. METHODS: Of 107 patients that had RA, 49 patients had anemia and 58 patients did not. We used ESR and CRP results to estimate the degree of disease activity. Thirty-eight patients having RA had a normal ESR and 69 patients had a high ESR. Sixty patients had normal CRP and 47 patients had high CRP. Sera of patients were tested for the presence of anti-human parvovirus B19 (IgG and IgM) using ELISA (Biotrin, Co. Dublin, Ireland). RESULTS: Of 107 patients who had RA, 79.4% (85/107) and 3.7% (4/107) were positive for IgG and IgM, respectively. There were no statistical differences between RA patients with anemia and those without anemia in the anti-human parvovirus B19 test (P>0.05). There were also no statistical differences between patients that had a normal or high ESR/CRP ratio (P>0.05). CONCLUSIONS: Human parvovirus B19 did not play a role in the formation of the chronic anemia of RA which is different from the cases of immunocompromised patients. Furthermore, we found no association between disease activity in RA and human parvovirus B19 infections.
Anemia* ; Arthritis, Rheumatoid* ; Enzyme-Linked Immunosorbent Assay ; Erythema Infectiosum ; Erythroid Precursor Cells ; Humans* ; Immunocompromised Host ; Immunoglobulin G ; Immunoglobulin M ; Parvovirus ; Parvovirus B19, Human*